Last update 23 Nov 2024

THDBH120

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
THDBH-120
Target
GIPR x GLP-1R
Mechanism
GIPR agonists(Gastric inhibitory polypeptide receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
ObesityDiabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
Active Organization
Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with THDBH120
CTR20242389 / RecruitingPhase 1
在中国肥胖受试者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学特征和初步有效性的随机、双盲、安慰剂对照的Ib期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase Ib clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of multiple doses of THDBH120 for injection in obese Chinese subjects
CTR20241940 / RecruitingPhase 1
在中国成人2型糖尿病患者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学和药效动力学的随机、双盲、安慰剂对照的Ib期临床试验
[Translation] A randomized, double-blind, placebo-controlled Phase Ib clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of THDBH120 for injection in Chinese adults with type 2 diabetes
CTR20234041 / RecruitingPhase 1
评价注射用THDBH120在中国健康成人中的安全性、耐受性及药代动力学、药效学特征：随机、双盲、安慰剂对照、单次和多次给药剂量递增的I期临床研究
[Translation] Evaluation of the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of THDBH120 for injection in healthy Chinese adults: a randomized, double-blind, placebo-controlled, single- and multiple-dose escalation phase I clinical study
100 Clinical Results associated with THDBH120
Login to view more data
100 Translational Medicine associated with THDBH120
Login to view more data
100 Patents (Medical) associated with THDBH120
Login to view more data
100 Deals associated with THDBH120
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPhase 1
CN
Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
18 Jul 2024
Diabetes Mellitus, Type 2Phase 1
CN
Dongbao Zixing (Hangzhou) Biomedical Co., Ltd.
19 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free